News Release

Serina Therapeutics to present at upcoming scientific conferences

Serina Therapeutics, Inc. is scheduled to present at three upcoming scientific meetings this summer.  Mr. Remy Gross, Business Development, will present at the American Association of Pharmaceutical Scientists National Biotechnology Conference in San Francisco on Monday, May 17^th.  The title of the abstract is “Polyoxazoline: a biopolymer for the delivery of proteins, peptides and small molecules”.

Dr. Milton Harris, President of Serina will present at the Polymer Therapeutics Conference in Valencia, Spain on May 26^th.  His talk will be in the session on New Synthetic Approaches in Polymer Therapeutics and is entitled “Modification of Biopharmaceuticals with Polyoxazoline (POZ)”.

Dr. Tacey Viegas, Chief Operating Officer of Serina will present at the Controlled Release Society annual meeting in Portland, Oregon on July 12^th.   His talk will be in the Polymers in Medicine session and is entitled “Polyoxazoline: a biopolymer for the delivery of proteins, peptides and small molecules”.

About Serina

Serina Therapeutics is a privately held biopharmaceutical company that develops novel polymer therapeutics based on its proprietary polyoxazoline (POZ) technology platforms.  The founders and managers of Serina were formerly the key principals of Shearwater Polymers, a company that enabled nine approved polyethylene glycol (PEG) products for various pharmaceutical partners.  Besides developing its own pipeline of biopharmaceuticals, Serina is also partnering its technology with pharmaceutical companies to develop high value products addressing unmet clinical needs.  

For more information on Serina Therapeutics, please visit http://www.serinatherapeutics.com